lohud.com

Sponsored by:

Business in the Burbs

Movers, shakers and newsmakers

Taro drug gets tentative approval for fungal infections treatment

March
27

Taro Pharmaceutical Industries Ltd., an Israel-based company with operations in Hawthorne, said this morning that it has gotten tentative federal approval for a product that treats fungal infections of the nails.

The U.S. Food and Drug Administration has determined that Ciclopirox is safe and effective compared with a product made by Sanofi-Aventi Pharmaceuticals. That product has annual sales in the United States of $88 million, Taro said.

Taro said the approval means it can market the product when patents and other restrictions expire, which is expected to happen in September.

Taro shares closed yesterday at $8.50, down 5 cents.

This entry was posted on Tuesday, March 27th, 2007 at 12:03 pm by Allan Drury.
You can follow any responses to this entry through the RSS 2.0 feed.
Share and Enjoy: del.icio.us Digg | Print Print | Email Email

Advertisement

Leave a Reply

About this blog
Business in the Burbs is our online news blog about businesses based or operating in the Lower Hudson Valley. Visitors here will also find items of interest to consumers in the region. Most contributions are from business reporters and editors covering Westchester, Rockland and Putnam counties.

Enter your email address to get daily updates from Business in the Burbs sent to your inbox:

About the Authors

Categories

Other recent entries


Latest LoHud Business news


Links

Monthly Archives